PMID- 27431801 OWN - NLM STAT- MEDLINE DCOM- 20170731 LR - 20240325 IS - 1471-244X (Electronic) IS - 1471-244X (Linking) VI - 16 DP - 2016 Jul 19 TI - Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression. PG - 247 LID - 10.1186/s12888-016-0964-9 [doi] LID - 247 AB - BACKGROUND: There are many studies in the literature on the association between depression treatment and health expenditures. However, there is a knowledge gap in examining this relationship taking into account coexisting chronic conditions among patients with diabetes. We aim to analyze the association between depression treatment and healthcare expenditures among adults with Type 2 Diabetes Mellitus (T2DM) and newly-diagnosed depression, with consideration of coexisting chronic physical conditions. METHODS: We used multi-state Medicaid data (2000-2008) and adopted a retrospective longitudinal cohort design. Medical conditions were identified using diagnosis codes (ICD-9-CM and CPT systems). Healthcare expenditures were aggregated for each month for 12 months. Types of coexisting chronic physical conditions were hierarchically grouped into: dominant, concordant, discordant, and both concordant and discordant. Depression treatment categories were as follows: antidepressants or psychotherapy, both antidepressants and psychotherapy, and no treatment. We used linear mixed-effects models on log-transformed expenditures (total and T2DM-related) to examine the relationship between depression treatment and health expenditures. The analyses were conducted on the overall study population and also on subgroups that had coexisting chronic physical conditions. RESULTS: Total healthcare expenditures were reduced by treatment with antidepressants (16 % reduction), psychotherapy (22 %), and both therapy types in combination (28 %) compared to no depression treatment. Treatment with both antidepressants and psychotherapy was associated with reductions in total healthcare expenditures among all groups that had a coexisting chronic physical condition. CONCLUSIONS: Among adults with T2DM and chronic conditions, treatment with both antidepressants and psychotherapy may result in economic benefits. FAU - Bhattacharya, Rituparna AU - Bhattacharya R AD - Humana Inc, Clinical Data Analytics (CODA), Tucson, AZ, USA. FAU - Shen, Chan AU - Shen C AD - Department of Health Services Research and Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. cshen@mdanderson.org. AD - Departments of Health Services Research, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1444, Houston, TX, 77030, USA. cshen@mdanderson.org. FAU - Wachholtz, Amy B AU - Wachholtz AB AD - Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA. FAU - Dwibedi, Nilanjana AU - Dwibedi N AD - Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, USA. FAU - Sambamoorthi, Usha AU - Sambamoorthi U AD - Department of Social & Behavioral Sciences, School of Public Health, West Virginia University, Morgantown, WV, USA. LA - eng GR - K23 DA030397/DA/NIDA NIH HHS/United States GR - U54 GM104942/GM/NIGMS NIH HHS/United States PT - Journal Article DEP - 20160719 PL - England TA - BMC Psychiatry JT - BMC psychiatry JID - 100968559 RN - 0 (Antidepressive Agents) SB - IM MH - Adult MH - Aged MH - Antidepressive Agents/therapeutic use MH - Chronic Disease/economics/*epidemiology MH - Combined Modality Therapy/economics MH - Comorbidity MH - Depression/economics/*epidemiology/therapy MH - Diabetes Mellitus, Type 2/economics/*epidemiology/therapy MH - Female MH - Health Care Costs/statistics & numerical data MH - Health Expenditures/*statistics & numerical data MH - Humans MH - Male MH - Middle Aged MH - Psychotherapy MH - Retrospective Studies MH - United States PMC - PMC4950075 OTO - NOTNLM OT - Comorbidity OT - Depression OT - Healthcare expenditures OT - Type 2 diabetes mellitus EDAT- 2016/07/20 06:00 MHDA- 2017/08/02 06:00 PMCR- 2016/07/19 CRDT- 2016/07/20 06:00 PHST- 2016/01/11 00:00 [received] PHST- 2016/07/08 00:00 [accepted] PHST- 2016/07/20 06:00 [entrez] PHST- 2016/07/20 06:00 [pubmed] PHST- 2017/08/02 06:00 [medline] PHST- 2016/07/19 00:00 [pmc-release] AID - 10.1186/s12888-016-0964-9 [pii] AID - 964 [pii] AID - 10.1186/s12888-016-0964-9 [doi] PST - epublish SO - BMC Psychiatry. 2016 Jul 19;16:247. doi: 10.1186/s12888-016-0964-9.